Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: A prospective multicenter randomized double-blind placebo-controlled trial

Lior Carmi, Aron Tendler, Alexander Bystritsky, Eric Hollander, Daniel M. Blumberger, Jeff Daskalakis, Herbert Ward, Kyle Lapidus, Wayne Goodman, Leah Casuto, David Feifel, Noam Barnea-Ygael, Yiftach Roth, Abraham Zangen, Joseph Zohar

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Obsessive-compulsive disorder (OCD) is a chronic and disabling condition that often responds unsatisfactorily to pharmacological and psychological treatments. Converging evidence suggests a dysfunction of the cortical-striatalthalamic-cortical circuit in OCD, and a previous feasibility study indicated beneficial effects of deep transcranial magnetic stimulation (dTMS) targeting the medial prefrontal cortex and the anterior cingulate cortex. The authors examined the therapeutic effect of dTMS in a multicenter double-blind sham-controlled study. Methods: At 11 centers, 99 OCD patients were randomly allocated to treatment with either high-frequency (20 Hz) or sham dTMS and received daily treatments following individualized symptom provocation, for 6 weeks. Clinical response to treatment was determined using the Yale-Brown Obsessive Compulsive Scale (YBOCS), and the primary efficacy endpoint was the change in score from baseline to posttreatment assessment. Additional measures were response rates (defined as a reduction of $30% in YBOCS score) at the posttreatment assessment and after another month of follow-up. Results: Eighty-nine percent of the active treatment group and 96% of the sham treatment group completed the study. The reduction in YBOCS score among patients who received active dTMS treatment was significantly greater than among patients who received sham treatment (reductions of 6.0 points and 3.3 points, respectively), with response rates of 38.1% and 11.1%, respectively. At the 1-month followup, the response rates were 45.2% in the active treatment group and 17.8% in the sham treatment group. Significant differences between the groups were maintained at follow-up. Conclusions: High-frequency dTMS over the medial prefrontal cortex and anterior cingulate cortex significantly improved OCD symptoms and may be considered as a potential intervention for patients who do not respond adequately to pharmacological and psychological interventions.

Original languageEnglish (US)
Pages (from-to)931-938
Number of pages8
JournalAmerican Journal of Psychiatry
Volume176
Issue number11
DOIs
StatePublished - Jan 1 2019

Fingerprint

Transcranial Magnetic Stimulation
Obsessive-Compulsive Disorder
Placebos
Safety
Gyrus Cinguli
Prefrontal Cortex
Therapeutics
Pharmacology
Psychology
Feasibility Studies
Therapeutic Uses

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder : A prospective multicenter randomized double-blind placebo-controlled trial. / Carmi, Lior; Tendler, Aron; Bystritsky, Alexander; Hollander, Eric; Blumberger, Daniel M.; Daskalakis, Jeff; Ward, Herbert; Lapidus, Kyle; Goodman, Wayne; Casuto, Leah; Feifel, David; Barnea-Ygael, Noam; Roth, Yiftach; Zangen, Abraham; Zohar, Joseph.

In: American Journal of Psychiatry, Vol. 176, No. 11, 01.01.2019, p. 931-938.

Research output: Contribution to journalArticle

Carmi, L, Tendler, A, Bystritsky, A, Hollander, E, Blumberger, DM, Daskalakis, J, Ward, H, Lapidus, K, Goodman, W, Casuto, L, Feifel, D, Barnea-Ygael, N, Roth, Y, Zangen, A & Zohar, J 2019, 'Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: A prospective multicenter randomized double-blind placebo-controlled trial', American Journal of Psychiatry, vol. 176, no. 11, pp. 931-938. https://doi.org/10.1176/appi.ajp.2019.18101180
Carmi, Lior ; Tendler, Aron ; Bystritsky, Alexander ; Hollander, Eric ; Blumberger, Daniel M. ; Daskalakis, Jeff ; Ward, Herbert ; Lapidus, Kyle ; Goodman, Wayne ; Casuto, Leah ; Feifel, David ; Barnea-Ygael, Noam ; Roth, Yiftach ; Zangen, Abraham ; Zohar, Joseph. / Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder : A prospective multicenter randomized double-blind placebo-controlled trial. In: American Journal of Psychiatry. 2019 ; Vol. 176, No. 11. pp. 931-938.
@article{7e64dcf7a9b2427e809e9b082229501f,
title = "Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: A prospective multicenter randomized double-blind placebo-controlled trial",
abstract = "Objective: Obsessive-compulsive disorder (OCD) is a chronic and disabling condition that often responds unsatisfactorily to pharmacological and psychological treatments. Converging evidence suggests a dysfunction of the cortical-striatalthalamic-cortical circuit in OCD, and a previous feasibility study indicated beneficial effects of deep transcranial magnetic stimulation (dTMS) targeting the medial prefrontal cortex and the anterior cingulate cortex. The authors examined the therapeutic effect of dTMS in a multicenter double-blind sham-controlled study. Methods: At 11 centers, 99 OCD patients were randomly allocated to treatment with either high-frequency (20 Hz) or sham dTMS and received daily treatments following individualized symptom provocation, for 6 weeks. Clinical response to treatment was determined using the Yale-Brown Obsessive Compulsive Scale (YBOCS), and the primary efficacy endpoint was the change in score from baseline to posttreatment assessment. Additional measures were response rates (defined as a reduction of $30{\%} in YBOCS score) at the posttreatment assessment and after another month of follow-up. Results: Eighty-nine percent of the active treatment group and 96{\%} of the sham treatment group completed the study. The reduction in YBOCS score among patients who received active dTMS treatment was significantly greater than among patients who received sham treatment (reductions of 6.0 points and 3.3 points, respectively), with response rates of 38.1{\%} and 11.1{\%}, respectively. At the 1-month followup, the response rates were 45.2{\%} in the active treatment group and 17.8{\%} in the sham treatment group. Significant differences between the groups were maintained at follow-up. Conclusions: High-frequency dTMS over the medial prefrontal cortex and anterior cingulate cortex significantly improved OCD symptoms and may be considered as a potential intervention for patients who do not respond adequately to pharmacological and psychological interventions.",
author = "Lior Carmi and Aron Tendler and Alexander Bystritsky and Eric Hollander and Blumberger, {Daniel M.} and Jeff Daskalakis and Herbert Ward and Kyle Lapidus and Wayne Goodman and Leah Casuto and David Feifel and Noam Barnea-Ygael and Yiftach Roth and Abraham Zangen and Joseph Zohar",
year = "2019",
month = "1",
day = "1",
doi = "10.1176/appi.ajp.2019.18101180",
language = "English (US)",
volume = "176",
pages = "931--938",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "11",

}

TY - JOUR

T1 - Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder

T2 - A prospective multicenter randomized double-blind placebo-controlled trial

AU - Carmi, Lior

AU - Tendler, Aron

AU - Bystritsky, Alexander

AU - Hollander, Eric

AU - Blumberger, Daniel M.

AU - Daskalakis, Jeff

AU - Ward, Herbert

AU - Lapidus, Kyle

AU - Goodman, Wayne

AU - Casuto, Leah

AU - Feifel, David

AU - Barnea-Ygael, Noam

AU - Roth, Yiftach

AU - Zangen, Abraham

AU - Zohar, Joseph

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Obsessive-compulsive disorder (OCD) is a chronic and disabling condition that often responds unsatisfactorily to pharmacological and psychological treatments. Converging evidence suggests a dysfunction of the cortical-striatalthalamic-cortical circuit in OCD, and a previous feasibility study indicated beneficial effects of deep transcranial magnetic stimulation (dTMS) targeting the medial prefrontal cortex and the anterior cingulate cortex. The authors examined the therapeutic effect of dTMS in a multicenter double-blind sham-controlled study. Methods: At 11 centers, 99 OCD patients were randomly allocated to treatment with either high-frequency (20 Hz) or sham dTMS and received daily treatments following individualized symptom provocation, for 6 weeks. Clinical response to treatment was determined using the Yale-Brown Obsessive Compulsive Scale (YBOCS), and the primary efficacy endpoint was the change in score from baseline to posttreatment assessment. Additional measures were response rates (defined as a reduction of $30% in YBOCS score) at the posttreatment assessment and after another month of follow-up. Results: Eighty-nine percent of the active treatment group and 96% of the sham treatment group completed the study. The reduction in YBOCS score among patients who received active dTMS treatment was significantly greater than among patients who received sham treatment (reductions of 6.0 points and 3.3 points, respectively), with response rates of 38.1% and 11.1%, respectively. At the 1-month followup, the response rates were 45.2% in the active treatment group and 17.8% in the sham treatment group. Significant differences between the groups were maintained at follow-up. Conclusions: High-frequency dTMS over the medial prefrontal cortex and anterior cingulate cortex significantly improved OCD symptoms and may be considered as a potential intervention for patients who do not respond adequately to pharmacological and psychological interventions.

AB - Objective: Obsessive-compulsive disorder (OCD) is a chronic and disabling condition that often responds unsatisfactorily to pharmacological and psychological treatments. Converging evidence suggests a dysfunction of the cortical-striatalthalamic-cortical circuit in OCD, and a previous feasibility study indicated beneficial effects of deep transcranial magnetic stimulation (dTMS) targeting the medial prefrontal cortex and the anterior cingulate cortex. The authors examined the therapeutic effect of dTMS in a multicenter double-blind sham-controlled study. Methods: At 11 centers, 99 OCD patients were randomly allocated to treatment with either high-frequency (20 Hz) or sham dTMS and received daily treatments following individualized symptom provocation, for 6 weeks. Clinical response to treatment was determined using the Yale-Brown Obsessive Compulsive Scale (YBOCS), and the primary efficacy endpoint was the change in score from baseline to posttreatment assessment. Additional measures were response rates (defined as a reduction of $30% in YBOCS score) at the posttreatment assessment and after another month of follow-up. Results: Eighty-nine percent of the active treatment group and 96% of the sham treatment group completed the study. The reduction in YBOCS score among patients who received active dTMS treatment was significantly greater than among patients who received sham treatment (reductions of 6.0 points and 3.3 points, respectively), with response rates of 38.1% and 11.1%, respectively. At the 1-month followup, the response rates were 45.2% in the active treatment group and 17.8% in the sham treatment group. Significant differences between the groups were maintained at follow-up. Conclusions: High-frequency dTMS over the medial prefrontal cortex and anterior cingulate cortex significantly improved OCD symptoms and may be considered as a potential intervention for patients who do not respond adequately to pharmacological and psychological interventions.

UR - http://www.scopus.com/inward/record.url?scp=85074379975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074379975&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.2019.18101180

DO - 10.1176/appi.ajp.2019.18101180

M3 - Article

C2 - 31109199

AN - SCOPUS:85074379975

VL - 176

SP - 931

EP - 938

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 11

ER -